Nuclear magnetic resonance mapping and functional confirmation of the collagen binding sites of matrix metalloproteinase-2

Biochemistry

Volumn 48, Issue 25, 2009, Pages 5822-5831

  Xu, Xiaoping ^a   Mikhailova, Margarita ^a   Ilangovan, Udayar ^a   Chen, Zhihua ^a   Yu, Agnes ^a   Pal, Sanjay ^a   Hinck, Andrew P ^a   Steffensen, Bjorn ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE SUBSTITUTION; CATALYTIC SITES; CHEMICAL SHIFT PERTURBATIONS; COLLAGEN BINDING; COLLAGEN BINDING DOMAIN; COLLAGEN PEPTIDES; CONCENTRATION-DEPENDENT; HIGH AFFINITY; MATRIX METALLOPROTEINASE-2; MICRO WELLS; NMR ANALYSIS; PROTEIN BINDING; SITE-SPECIFIC; SUBSTRATE BINDING; TYPE I COLLAGEN; TYPE II;

AMIDES; AMINES; BINDING ENERGY; CHEMICAL SHIFT; COLLAGEN; DENATURATION; NUCLEAR MAGNETIC RESONANCE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; SUBSTRATES; SURFACE PLASMON RESONANCE; ULSI CIRCUITS; YTTRIUM ALLOYS;

BINDING SITES;

ALANINE; COLLAGEN BINDING PROTEIN; COLLAGEN TYPE 1; GELATINASE A;

AMINO ACID SUBSTITUTION; ARTICLE; BINDING AFFINITY; BINDING SITE; CONTROLLED STUDY; HUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; SURFACE PLASMON RESONANCE;

BINDING SITES; COLLAGEN; FIBRONECTINS; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MATRIX METALLOPROTEINASE 2; PEPTIDE MAPPING; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; STRUCTURAL HOMOLOGY, PROTEIN;

EID: 67649610424     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi900513h     Document Type: Article

References (37)

1. Sternlicht, M. D., and Werb, Z. (2001) How matrix metalloproteinases regulate cell behavior. Annu. Rev. Cell Dev. Biol. 17, 463-516.
2. Smith, P. C., Munoz, V. C., Collados, L., and Oyarzun, A. D. (2004) In situ detection of matrix metalloproteinase-9 (MMP-9) in gingival epitheliumin human periodontal disease. J. Periodontal Res. 39, 87-92.
3. Armstrong, D. G., and Jude, E. B. (2002) The role of matrix metalloproteinases in wound healing. J. Am. Podiatr. Med. Assoc. 92, 12-18.
4. Mott, J. D., and Werb, Z. (2004) Regulation of matrix biology by matrix metalloproteinases. Curr. Opin. Cell Biol. 16, 558-564.
5. Liotta, L. A., Steeg, P. S., and Stetler-Stevenson, W. G. (1991) Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation. Cell 64, 327-336. (Pubitemid 121001258)
6. Van Wart, H. E., and Birkedal-Hansen, H. (1990) The cysteine switch: A principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family. Proc. Natl. Acad. Sci. U.S.A. 87, 5578-5582.
7. Becker, J. W., Marcy, A. I., Rokosz, L. L., Axel, M. G., Burbaum, J. J., Fitzgerald, P. M., Cameron, P. M., Esser, C. K., Hagmann, W. K., and Hermes, J. D. (1995) Stromelysin-1: Three-dimensional structure of the inhibited catalytic domain and of the C-truncated proenzyme. Protein Sci. 4, 1966-1976.
8. Bode, W., Gomis-Ruth, F. X., and Stockler, W. (1993) Astacins, serralysins, snake venom and matrix metalloproteinases exhibit identical zinc-binding environments (HEXXHXXGXXH and Met-turn) and topologies and should be grouped into a common family, the 'metzincins'. FEBS Lett. 331, 134-140.
9. 2+ for fibronectin and heparin binding. Binding properties of recombinant gelatinase A C domain to extracellular matrix and basement membrane components. J. Biol. Chem. 272, 7473-7481.
10. Murphy, G., and Knauper, V. (1997) Relating matrix metalloproteinase structure to function: Why the "hemopexin" domain?. Matrix Biol. 15, 511-518.
11. Allan, J. A., Docherty, A. J., Barker, P. J., Huskisson, N. S., Reynolds, J. J., and Murphy, G. (1995) Binding of gelatinases A and B to type-I collagen and other matrix components. Biochem. J. 309 (Part 1), 299-306.
12. Steffensen, B., Wallon, U. M., and Overall, C. M. (1995) Extracellular matrix binding properties of recombinant fibronectin type II-like modules of human 72-kDa gelatinase/type IV collagenase. High affinity binding to native type I collagen but not native type IV collagen. J. Biol. Chem. 270, 11555-11566.
13. Banyai, L., and Patthy, L. (1991) Evidence for the involvement of type II domains in collagen binding by 72 kDa type IV procollagenase. FEBS Lett. 282, 23-25.
14. Steffensen, B., Xu, X., Martin, P. A., and Zardeneta, G. (2002) Human fibronectin and MMP-2 collagen binding domains compete for collagen binding sites and modify cellular activation of MMP-2. Matrix Biol. 21, 399-414. (Pubitemid 35286606)
15. Xu, X., Chen, Z., Wang, Y., Yamada, Y., and Steffensen, B. (2005) Functional basis for the overlap in ligand interactions and substrate specificities of matrix metalloproteinases-9 and -2. Biochem. J. 392, 127-134. (Pubitemid 41689408)
16. Murphy, G., Nguyen, Q., Cockett, M. I., Atkinson, S. J., Allan, J. A., Knight, C. G., Willenbrock, F., and Docherty, A. J. (1994) Assessment of the role of the fibronectin-like domain of gelatinase A by analysis of a deletion mutant. J. Biol. Chem. 269, 6632-6636.
17. Shipley, J. M., Doyle, G. A., Fliszar, C. J., Ye, Q. Z., Johnson, L. L., Shapiro, S. D., Welgus, H. G., and Senior, R. M. (1996) The structural basis for the elastolytic activity of the 92-kDa and 72- kDa gelatinases. Role of the fibronectin type II-like repeats. J. Biol. Chem. 271, 4335-4341.
18. Xu, X., Wang, Y., Lauer-Fields, J. L., Fields, G. B., and Steffensen, B. (2004) Contributions of the MMP-2 collagen binding domain to gelatin cleavage. Substrate binding via the collagen binding domain is required for hydrolysis of gelatin but not short peptides. Matrix Biol. 23, 171-181.
19. Banyai, L., Tordai, H., and Patthy, L. (1994) The gelatin-binding site of human 72 kDa type IV collagenase (gelatinase A). Biochem. J. 298 (Part 2), 403-407. (Pubitemid 24072484)
20. Collier, I. E., Krasnov, P. A., Strongin, A. Y., Birkedal-Hansen, H., and Goldberg, G. I. (1992) Alanine scanning mutagenesis and functional analysis of the fibronectin-like collagen-binding domain from human 92-kDa type IV collagenase. J. Biol. Chem. 267, 6776-6781.
21. Morgunova, E., Tuuttila, A., Bergmann, U., Isupov, M., Lindqvist, Y., Schneider, G., and Tryggvason, K. (1999) Structure of human pro-matrix metalloproteinase-2: Activation mechanism revealed. Science 284, 1667-1670. (Pubitemid 29291376)
22. Briknarova, K., Grishaev, A., Banyai, L., Tordai, H., Patthy, L., and Llinas, M. (1999) The second type II module from human matrix metalloproteinase 2: Structure, function and dynamics. Structure 7, 1235-1245. (Pubitemid 29482985)
23. Tordai, H., and Patthy, L. (1999) The gelatin-binding site of the second type-II domain of gelatinase A/MMP-2. Eur. J. Biochem. 259, 513-518.
24. Gehrmann,M. L., Douglas, J. T., Banyai, L., Tordai, H., Patthy, L., and Llinas, M. (2004) Modular autonomy, ligand specificity, and functional cooperativity of the three in-tandem fibronectin type II repeats from human matrix metalloproteinase 2. J. Biol. Chem. 279, 46921-46929.
25. Xu, X., Chen, Z., Wang, Y., Bonewald, L., and Steffensen, B. (2007) Inhibition of MMP-2 gelatinolysis by targeting exodomain-substrate interactions. Biochem. J. 406, 147-155. (Pubitemid 47264745)
26. Sambrook, J., and Russell, D. W. (2001) Molecular Cloning: A Laboratory Manual , Cold Spring Harbor Laboratory Press, Plainview, NY.
27. Rehm, T., Huber, R., and Holak, T. A. (2002) Application of NMR in structural proteomics: Screening for proteins amenable to structural analysis. Structure 10, 1613-1618. (Pubitemid 35447976)
28. Steffensen, B., Bigg, H. F., and Overall, C. M. (1998) The involvement of the fibronectin type II-like modules of human gelatinase A in cell surface localization and activation. J. Biol. Chem. 273, 20622-20628.
29. Briknarova, K., Gehrmann, M., Banyai, L., Tordai, H., Patthy, L., and Llinas, M. (2001) Gelatin-binding region of human matrix metalloproteinase-2: Solution structure, dynamics, and function of the COL-23 two-domain construct. J. Biol. Chem. 276, 27613-27621.
30. Brown, P. D. (1998) Matrix metalloproteinase inhibitors. Breast Cancer Res. Treat. 52, 125-136.
31. Brown, S., Meroueh, S. O., Fridman, R., and Mobashery, S. (2004) Quest for selectivity in inhibition of matrix metalloproteinases. Curr. Top. Med. Chem. 4, 1227-1238.
32. Overall, C. M., and Lopez-Otin, C. (2002) Strategies for MMP inhibition in cancer: Innovations for the post-trial era. Nat. Rev. Cancer 2, 657-672.
33. Murphy, G., Allan, J. A., Willenbrock, F., Cockett, M. I., O'Connell, J. P., and Docherty, A. J. (1992) The role of the C-terminal domain in collagenase and stromelysin specificity. J. Biol. Chem. 267, 9612-9618.
34. Constantine, K. L., Madrid, M., Banyai, L., Trexler, M., Patthy, L., and Llinas, M. (1992) Refined solution structure and ligand-binding properties of PDC-109 domain b. A collagen-binding type II domain. J. Mol. Biol. 223, 281-298.
35. Gehrmann, M., Briknarova, K., Banyai, L., Patthy, L., and Llinas, M. (2002) The col-1 module of human matrix metalloproteinase-2 (MMP-2): Structural/functional relatedness between gelatin-binding fibronectin type II modules and lysine-binding kringle domains. Biol. Chem. 383, 137-148.
36. Trexler, M., Briknarova, K., Gehrmann, M., Llinas, M., and Patthy, L. (2003) Peptide ligands for the fibronectin type II modules of matrix metalloproteinase 2 (MMP-2). J. Biol. Chem. 278, 12241-12246. (Pubitemid 36800205)
37. Tam, E. M., Moore, T. R., Butler, G. S., and Overall, C. M. (2004) Characterization of the distinct collagen binding, helicase and cleavage mechanisms of matrix metalloproteinase 2 and 14 (gelatinase A and MT1-MMP): The differential roles of the MMP hemopexin c domains and the MMP-2 fibronectin type II modules in collagen triple helicase activities. J. Biol. Chem. 279, 43336-43344.